Treatment of sleeping disorders should be considered in clinical management of Parkinson's disease

Frontiers in Aging Neuroscience

Volumn 6, Issue OCT, 2014, Pages

  dos Santos, Altair Brito ^a   Barreto, George E ^b   Kohlmeier, Kristi A ^c  

^a UNIVERSIDADE ESTADUAL DO SUDOESTE DA BAHIA   (Brazil)

^b PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Excessive daytime sleepiness; Mesopontine cholinergic cell group; Neurodegeneration; REM sleep behavior disorder; Restless leg syndrome

Indexed keywords

AMYLOID BETA PROTEIN;

ARTICLE; CELL LOSS; DAYTIME SOMNOLENCE; DISEASE COURSE; EXCESSIVE DAYTIME SLEEPINESS; GAIT DISORDER; HUMAN; MOTOR DYSFUNCTION; NERVE CELL DEGENERATION; NONHUMAN; PARASOMNIA; PARKINSON DISEASE; SLEEP DISORDER; SLEEP WAKING CYCLE;

EID: 84922417739     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00273     Document Type: Article

References (27)

1. Abbott, R.D., Ross, G.W., White, L.R., Tanner, C.M., Masaki, K.H., Nelson, J.S., et al. (2005). Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 65, 1442-1446. doi: 10.1212/01.wnl.0000183056.89590.0d
2. Arnulf, I., Konofal, E., Merino-Andreu, M., Houeto, J.L., Mesnage, V., Welter, M.L., et al. (2002). Parkinson's disease and sleepiness: an integral part of PD. Neurology 58, 1019-1024. doi: 10.1212/WNL.58.7.1019
3. Arnulf, I., Leu, S., and Oudiette, D. (2008). Abnormal sleep and sleepiness in Parkinson's disease. Curr. Opin. Neurol. 21, 472-477. doi: 10.1097/WCO.0b013e328305044d
4. Barraud, Q., Lambrecq, V., Forni, C., McGuire, S., Hill, M., Bioulac, B., et al. (2009). Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model. Exp. Neurol. 219, 574-582. doi: 10.1016/j.expneurol.2009.07.019
5. Breen, D.P., Vuono, R., Nawarathna, U., Fisher, K., Shneerson, J.M., Reddy, A.B., et al. (2014). Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol. 71, 589-595. doi: 10.1001/jamaneurol.2014.65
6. De Cock, V.C., Vidailhet, M., and Arnulf, I. (2008). Sleep disturbances in patients with parkinsonism. Nat. Clin. Pract. Neurol. 4, 254-266. doi: 10.1038/ncpneuro0775
7. Diederich, N.J., and McIntyre, D.J. (2012). Sleep disorders in Parkinson's disease: many causes, few therapeutic options. J. Neurol. Sci. 314, 12-19. doi: 10.1016/j.jns.2011.10.025
8. Fantini, M.L., Farini, E., Ortelli, P., Zucconi, M., Manconi, M., Cappa, S., et al. (2011). Longitudinal study of cognitive function in idiopathic REM sleep behavior disorder. Sleep 34, 619-625. doi: 10.5665/Sleep.3050
9. Gao, J., Huang, X., Park, Y., Hollenbeck, A., Blair, A., Schatzkin, A., et al. (2011). Daytime napping, nighttime sleeping, and Parkinson disease. Am. J. Epidemiol. 173, 1032-1038. doi: 10.1093/aje/kwq478
10. Hansen, I.H., Marcussen, M., Christensen, J.A., Jennum, P., and Sorensen, H.B. (2013). Detection of a sleep disorder predicting Parkinson's disease. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2013, 5793-5796. doi: 10.1109/EMBC.2013.6610868
11. Jahan, I., Hauser, R.A., Sullivan, K.L., Miller, A., and Zesiewicz, T.A. (2009). Sleep disorders in Parkinson's disease. Neuropsychiatr. Dis. Treat. 5, 535-540. doi: 10.2147/NDT.54578
12. Kang, J.E., Lim, M.M., Bateman, R.J., Lee, J.J., Smyth, L.P., Cirrito, J.R., et al. (2009). Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005-1007. doi: 10.1126/science.1180962
13. Klingelhoefer, L., Sokolov, E., and Chaudhuri, K.R. (2014). Therapeutic options for nocturnal problems in Parkinson's disease and atypical parkinsonian disorders. J. Neural Transm. 121 Suppl. 1, S25-S31. doi: 10.1007/s00702-014-1202-6
14. Korczyn, A.D. (2006). Management of sleep problems in Parkinson's disease. J. Neurol. Sci. 248, 163-166. doi: 10.1016/j.jns.2006.05.041
15. Peppe, A., Pierantozzi, M., Baiamonte, V., Moschella, V., Caltagirone, C., Stanzione, P., et al. (2012). Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. Sleep 35, 1637-1642. doi: 10.5665/sleep.2234
16. Postuma, R.B., Gagnon, J.F., Vendette, M., Fantini, M.L., Massicotte-Marquez, J., and Montplaisir, J. (2009b). Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 72, 1296-1300. doi: 10.1212/01.wnl.0000340980.19702.6e
17. Postuma, R.B., Gagnon, J.F., Vendette, M., and Montplaisir, J.Y. (2009a). Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease. Brain 132, 3298-3307. doi: 10.1093/brain/awp244
18. Schenck, C.H., Bundlie, S.R., Ettinger, M.G., and Mahowald, M.W. (2002). Chronic behavioral disorders of human REM sleep: a new category of parasomnia. 1986 [classical article]. Sleep 25, 293-308. doi: 10.1016/JMCNA.2010.02.010
19. Schenck, C.H., Bundlie, S.R., and Mahowald, M.W. (1996). Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46, 388-393. doi: 10.1212/WNL.46.2.388
20. Schenck, C.H., and Mahowald, M.W. (2002). REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 25, 120-138. doi: 10.1016/J. Sleep.2009.06.008
21. Stavitsky, K., and Cronin-Golomb, A. (2011). Sleep quality in Parkinson disease: an examination of clinical variables. Cogn. Behav. Neurol. 24, 43-49. doi: 10.1097/WNN.0b013e31821a4a95
22. Thannickal, T.C., Lai, Y.Y., and Siegel, J.M. (2007). Hypocretin (orexin) cell loss in Parkinson's disease. Brain 130, 1586-1595. doi: 10.1093/brain/awm097
23. Tippmann-Peikert, M., Boeve, B.F., and Keegan, B.M. (2006). REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology 66, 1277-1279. doi: 10.1212/01.wnl.0000208518.72660.ff
24. Verhave, P.S., Jongsma, M.J., Van den Berg, R.M., Vis, J.C., Vanwersch, R.A., Smit, A.B., et al. (2011). REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease. Sleep 34, 1119-1125. doi: 10.5665/SLEEP.1174
25. Wong, J.C., Li, Y., Schwarzschild, M.A., Ascherio, A., and Gao, X. (2014). Restless legs syndrome: an early clinical feature of Parkinson disease in men. Sleep 37, 369-372. doi: 10.5665/sleep.3416
26. Xie, L., Kang, H., Xu, Q., Chen, M.J., Liao, Y., Thiyagarajan, M., et al. (2013). Sleep drives metabolite clearance from the adult brain. Science 342, 373-377. doi: 10.1126/science.1241224
27. Zweig, R.M., Jankel, W.R., Hedreen, J.C., Mayeux, R., and Price, D.L. (1989). The pedunculopontine nucleus in Parkinson's disease. Ann. Neurol. 26, 41-46. doi: 10.1002/ana.410260106